Slow-release preparation containing quinolones antibiotics
A technology of quinolones and antibiotics, applied in the direction of anti-inflammatory agents, antibacterial drugs, non-central analgesics, etc., can solve the problems of difficult to obtain effective bactericidal concentration, increase dose side effects, etc., to facilitate the application of drugs and reduce the course of treatment , the effect of shortening the treatment time
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0104] Put 90, 80 and 70 mg polyphenylene propane (p-CPP: sebacic acid (SA) at 20: 80) copolymer into (A), (B) and (C) three In two containers, add 100 milliliters of dichloromethane to each, after dissolving and mixing, add 10 mg pazufloxacin, 20 mg ciprofloxacin, and 30 mg fleroxacin respectively, re-shake and use spray-drying method to prepare 10% Pazufloxacin, 20% ciprofloxacin, 30% fleroxacin microspheres for injection. Then suspend the microspheres in physiological saline containing 15% mannitol to prepare the corresponding suspension-type sustained-release injection. The viscosity of the injection is 450cp-600cp (at 20°C-30°C). The drug release time of the slow-release injection in physiological saline in vitro is 5-15 days, and the drug release time in mice subcutaneous is about 12-20 days.
Embodiment 2
[0106] The method step of being processed into sustained-release injection is the same as that of Example 1, but the difference is that the contained antibacterial active ingredients and their weight percentages are: 2-50% of Pazufloxacin, Ciprofloxacin, Clinfloxacin, and Fleroxacin , cillofloxacin, levofloxacin, enoxacin, grafloxacin, tosufloxacin, amfloxacin, lomefloxacin, R-lomefloxacin, prefloxacin, orbimycin, Prulifloxacin, Olafloxacin, Cadrifloxacin, Alatrafloxacin, Gatifloxacin, Moxifloxacin, Gemifloxacin, Sitafloxacin, Nilefloxacin, Norfloxacin, Danoxacin , enrofloxacin, difloxacin, marbofloxacin, pemafloxacin, safloxacin, ibafloxacin, rufloxacin, tosufloxacin, pefloxacin, or spafloxacin .
Embodiment 3
[0108] Put 70 mg of polylactic acid (PLGA, 75:25) with a peak molecular weight of 10,000 into three containers (A), (B) and (C) respectively, and then add 100 ml of dichloromethane to each, dissolve and mix well , add 30mg of ciloxacin, levofloxacin and enoxacin to three containers respectively, re-shake and use spray drying method to prepare 30% ciloxacin, levofloxacin and enoxacin Microspheres for Injection of Floxacin. The dried microspheres are suspended in physiological saline containing 1.5% sodium carboxymethylcellulose to prepare the corresponding suspension-type sustained-release injection. The viscosity of the injection is 400cp-600cp (at 20°C-30°C). The drug release time of the slow-release injection in physiological saline in vitro is 7-15 days, and the drug release time in mice subcutaneous is about 15-25 days.
PUM
Property | Measurement | Unit |
---|---|---|
glass transition temperature | aaaaa | aaaaa |
melting point | aaaaa | aaaaa |
glass transition temperature | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com